Gibson, Dunn & Crutcher LLP advised 89bio, Inc. on its upsized public offering. 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now